Affyimmune Competitors and Similar CompaniesClear all
Legend Biotech's competitors and similar companies include Seagen.
 Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
|  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | |
Founding Date | Founding Date 2014 | Founding Date 1998 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more |
Employees | Employees 2,90012% increase | Employees 3,25622% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $1b (FY, 2025) | Revenue (est.) $2b (FY, 2022) |
Cost of goods | Cost of goods $408.1m (FY, 2025) | Cost of goods $410.1m (FY, 2022) |
Gross profit | Gross profit $620.8m (FY, 2025) | Gross profit $1.6b (FY, 2022) |
Net income | Net income ($296.8m) (FY, 2025) | Net income ($610.3m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 150.5m | Total funding raised $ 164m |
For sources of this data, please see the company profile
View Company Profiles
Seagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View company